Timentin and Death - a phase IV clinical study of FDA data

Summary:

Death is reported as a side effect among people who take Timentin (clavulanate potassium; ticarcillin disodium), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Zometa, and have Breast cancer.

The study is created by eHealthMe based on reports of 619 people who have side effects when taking Timentin from the FDA, and is updated regularly.

What is Timentin?

Timentin has active ingredients of clavulanate potassium; ticarcillin disodium. eHealthMe is studying from 624 Timentin users. Check the latest studies of Timentin.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Jul, 30, 2026

619 people reported to have side effects when taking Timentin.
Among them, 33 people (5.33%) died.

Among these 33 people:

How long have people been on Timentin when they died? *

What is the gender of people who died when taking Timentin? *

female: 75.76 %
male: 24.24 %

What is the age of people who died when taking Timentin? *

What are other drugs people take besides Timentin? *

What are other side effects people have before they died? *

Pain: 17 people, 51.52%
Stress And Anxiety: 17 people, 51.52%
Injury: 17 people, 51.52%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 16 people, 48.48%
Deep Venous Thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis): 16 people, 48.48%
Bone Disorder: 16 people, 48.48%
Constipation: 15 people, 45.45%
Osteonecrosis Of Jaw (death of bone of jaw): 13 people, 39.39%
Oedema Peripheral (superficial swelling): 12 people, 36.36%
Dizziness: 11 people, 33.33%

What are the existing conditions these people have? *

Stress And Anxiety: 9 people, 27.27%
Reflux Gastritis (a condition in which the lining of a person's stomach becomes inflamed as a result of exposure to bile): 9 people, 27.27%
Pain: 9 people, 27.27%
Breast Cancer: 9 people, 27.27%
Multiple Myeloma (cancer of the plasma cells): 7 people, 21.21%
Stenotrophomonas Infection: 4 people, 12.12%
White Blood Cell Count Abnormal: 2 people, 6.06%
Pneumonia: 2 people, 6.06%
Stenotrophomonas Sepsis (blood infection by stenotrophomonas): 1 person, 3.03%
Paroxysmal Nocturnal Haemoglobinuria (haemoglobin in the urine): 1 person, 3.03%

* Approximation only. Some reports may have incomplete information.

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Timentin:

Timentin (624 reports)

Expand to all the drugs that have ingredients of clavulanate potassium; ticarcillin disodium:

Death and drugs with ingredients of clavulanate potassium; ticarcillin disodium (34 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Timentin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Death:

Death (3,114 drugs)

Browse all the conditions that are associated with Death:

Death (3,686 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on clavulanate potassium; ticarcillin disodium (the active ingredients of Timentin) and Timentin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.